Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2010
12/02/2010WO2010138263A2 Novel aav 's and uses thereof
12/02/2010WO2010138084A1 CRYSTAL STRUCTURE OF CAP-FREE HUMAN eIF4E
12/02/2010WO2010137770A1 Novel gpcr protein and use of same
12/02/2010WO2010137717A1 Method for highly sensitive detection of protein-protein interaction
12/02/2010WO2010137295A1 Cdc45l peptides and vaccines including the same
12/02/2010WO2010137020A1 Methods of treating inflammation
12/02/2010WO2010137012A1 Peptide therapy for amphiregulin mediated diseases
12/02/2010WO2010136897A2 Expression of recombinant proteins
12/02/2010WO2010136896A1 Assays for influenza virus hemagglutinins
12/02/2010WO2010136877A1 Muteins of the pyrroline-5-carboxylate reductase 1
12/02/2010WO2010136841A2 Meganuclease variants cleaving the genome of a non-genomically integrating virus and uses thereof
12/02/2010WO2010136754A1 Novel polypeptides having endolysin activity and uses thereof
12/02/2010WO2010136622A1 Use of rgs-14 protein in order to produce a memory enhancer
12/02/2010WO2010136621A1 Use of rgs-14 protein in order to produce a drug for the treatment or prevention of cognitive and memory disorders
12/02/2010WO2010136536A1 Anti-ck8 antibodies to be used for treating colorectal cancers and identifying metastatic and/or invasive phenotypes
12/02/2010WO2010136492A2 Antigen-binding proteins
12/02/2010WO2010136480A1 Antigen-binding proteins
12/02/2010WO2010136476A1 Extraneous agents testing
12/02/2010WO2010136443A1 Casb7439 constructs
12/02/2010WO2010136209A1 N-glycan core beta-galactosyltransferase and uses thereof
12/02/2010WO2010136182A1 Methylglyoxal-scavenging compounds and their use for the prevention and treatment of pain and/or hyperalgesia
12/02/2010WO2010136031A1 Fibroblast growth factor receptor-derived peptides binding to ncam
12/02/2010WO2010135813A1 Increased seed oil and abiotic stress tolerance mediated by hsi2
12/02/2010WO2010135786A1 A method for diagnosing neoplasms and molecules for use therein
12/02/2010WO2010117725A3 Production of peptides containing poly-gly sequences using fmoc chemistry
12/02/2010WO2010115843A3 Pharmaceutical composition
12/02/2010WO2010115278A8 Methods and compositions for treating and preventing shiga toxin-producing escherichia coli infection
12/02/2010WO2010115033A9 Nucleotide repeat expansion-associated polypeptides and uses thereof
12/02/2010WO2010098788A3 Pd-i antagonists and methods for treating infectious disease
12/02/2010WO2010097709A3 Polypeptides for the prevention or treatment of malaria
12/02/2010WO2010087743A3 The use of basigin-1 in stem cell and cancer applications
12/02/2010WO2010064204A3 Modified protozoan expressing at least two variable surface proteins (vsp), a vaccine comprising it and procedures, uses, and methods thereof
12/02/2010WO2010062756A3 Preventing and treating sepsis
12/02/2010US20100306881 improved ability to enzymatically degrade lignocellulosic feedstock; fermentation
12/02/2010US20100306876 Meg1 endosperm-specific promoters and genes
12/02/2010US20100306875 Resistance gene and uses thereof
12/02/2010US20100305308 Lactoferrin
12/02/2010US20100305306 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
12/02/2010US20100305305 Method for purifying factor viii and von willebrand factor
12/02/2010US20100305304 Non-natural proteinaceous scaffold made of three non-covalently associated peptides
12/02/2010US20100305194 Modified and stabilized gdf propeptides and uses thereof
12/02/2010US20100305049 Novel Wheat Allergens
12/02/2010US20100305041 Cell permeable p18 recombinant proteins, polynucleotides encoding the same, and anticancer composition comprising the same
12/02/2010US20100305039 Production of collagen in the milk of transgenic mammals
12/02/2010US20100305034 Growth factor isoform
12/02/2010US20100305032 Novel GLP-1 Derivatives
12/02/2010US20100305031 Peptide having an extending action for half-life of object peptide in plasma
12/02/2010US20100305029 Paralytic Peptide for Use in Neuromuscular Therapy
12/02/2010US20100305028 Cholesterol derivatives of inhibitors of viral fusion
12/02/2010US20100305025 Rnase a peptides, fragments and uses thereof
12/02/2010US20100305004 Polynucleotide backbones for complexing proteins
12/02/2010US20100304497 Fluorescent protein and chromoprotein
12/02/2010US20100304476 Expression of Human Serum Albumin in Plastids
12/02/2010US20100304435 Fluorescent proteins, their production and use
12/02/2010US20100304434 Polypeptides having Cellulolytic Enhancing Activity and Polynucleotides Encoding Same
12/02/2010US20100304405 Combinatorial discovery of enzymes with utility in biomass transformation
12/02/2010US20100304402 Chimeric human sweet-umami and umami-sweet taste receptors
12/02/2010US20100304401 Ys68 gene involved in primitive hematopoiesis
12/02/2010US20100304392 Hepatitis b viral variants with reduced susceptibility to nucleoside analogs and uses thereof
12/02/2010US20100303993 Novel soybean protein material and method for producing the same
12/02/2010US20100303958 Methods for Casein Production
12/02/2010US20100303897 Novel addl receptor polypeptides, polynucleotides and host cells for recombinant production
12/02/2010US20100303884 Growth factor complexes and modulation of cell migration and growth
12/02/2010US20100303864 Conserved and specific streptococcal genomes
12/02/2010US20100303858 Chimeric HIV-1 Glycoproteins and Their Biological Applications
12/02/2010US20100303857 Development of a preventive vaccine for filovirus infection in primates
12/02/2010US20100303856 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
12/02/2010US20100303852 Conjugation process for pnag and a carrier protein
12/02/2010US20100303851 Immunostimulation by chemically modified rna
12/02/2010US20100303849 Lipidated Vaccine against Dengue Virus Infection
12/02/2010US20100303848 Vaccination method
12/02/2010US20100303845 Novel gene expressed in prostate cancer
12/02/2010US20100303843 RECOMBINANT ALLERGEN WITH REDUCED lgE BINDING BUT UNDIMINISHED T-CELL ANTIGENICITY
12/02/2010US20100303824 Signaling intermediates in an in vitro model of alzheimer's disease
12/02/2010US20100303822 Polypeptides from non-typeable haemophilus influenzae
12/02/2010US20100303820 Methods of treatment using il-17e antagonists
12/02/2010US20100303818 Dendritic cell receptor
12/02/2010US20100303815 METHOD OF TREATING ANEMIA BY ADMINISTERING IL 1ra
12/02/2010US20100303814 Antibodies Against a Cancer-Associated Epitope of Variant HNRNPG and Uses Thereof
12/02/2010US20100303811 Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity.
12/02/2010US20100303797 Use of p97 As An Enzyme Delivery System For The Delivery of Therapeutic Lysosomal Enzymes
12/02/2010US20100303785 Novel therapeutics based on tau/microtubule dynamics
12/02/2010US20100303761 Lipidized Interferon and Uses Thereof
12/02/2010US20100303759 polynucleotide encoding a protein that is non-naturally occurring and has enhanced anti-viral and anti-proliferative activity in comparison to human interferon alpha 2b (HuIFN- alpha 2b); treating cancer responsive to interferon alpha therapy
12/02/2010US20100303754 Process for preparation of cyclodextrin oligomers or polymers, products obtained and uses
12/02/2010US20100303729 Cyanochrome fluorophores
12/02/2010US20100303723 Drug delivery systems using fc fragments
12/02/2010US20100303715 Prostate-specific membrane antigen and uses thereof
12/02/2010CA2763641A1 Expression of recombinant proteins
12/02/2010CA2763486A1 Casb7439 constructs
12/02/2010CA2763469A1 Antigen-binding proteins
12/02/2010CA2763466A1 Fibromodulin peptide
12/02/2010CA2763440A1 Assays for influenza virus hemagglutinins
12/02/2010CA2763439A1 Antigen-binding proteins
12/02/2010CA2763341A1 Novel polypeptides having endolysin activity and uses thereof
12/02/2010CA2763327A1 Inhibition 0f inflammation using antagonists of muc1
12/02/2010CA2763105A1 N-glycan core beta-galactosyltransferase and uses thereof
12/02/2010CA2762934A1 Cdc45l peptides and vaccines including the same
12/02/2010CA2762260A1 Extraneous agents testing
12/02/2010CA2762204A1 Increased seed oil and abiotic stress tolerance mediated by hsi2
1 ... 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 ... 2916